@Bob
The market runs its own affairs. The stock is obviously drawn to its recent turning point at 1.89. If they announced the exclusive licensing of their cancer applications, for an upfront of half a billion, the market would have no choice. But there is always some excuse. I suppose, if West introduced mice that can regrow eyes, ears and legs, and are expected to last 1,000 years, we’d drop to an all-time low. I wish I could load, but none of what I‘m trying to sell, is even trading today. And what I could sell, I don’t feel like selling.
News 
Market Data 
Discover 
